Screening for central precocious puberty by single basal Luteinizing Hormone levels.

Bibliographic Details
Title: Screening for central precocious puberty by single basal Luteinizing Hormone levels.
Authors: Li Pomi, Alessandra, Scalini, Perla, De Masi, Salvatore, Corica, Domenico, Pepe, Giorgia, Wasniewska, Malgorzata, Stagi, Stefano
Source: Endocrine (1355008X); Aug2024, Vol. 85 Issue 2, p955-963, 9p
Abstract: Purpose: To identify cut-off for basal LH levels and for pelvic ultrasound uterine and ovarian parameters indicating an Hypotalamic–Pituitary–Gonadal (HPG) axis activation as diagnostic of Central Precocious Puberty (CPP). Methods: 248 girls referred for suspected precocious/early puberty who had undergone a GnRH stimulation test were enrolled and divided into three groups: Premature Idiopathic Thelarche (PIT), CPP, and Early Puberty (EA). For every patient basal serum Luteinising Hormone (LH) and Follicle Stimulating Hormone (FSH), basal LH/FSH ratio and pelvic ultrasonographic parameters were also collected. Through the use of Receiver Operating Curves (ROCs) the sensitivity (Se) and specificity (Sp) of basal LH, FSH, LH/FSH ratio and ultrasonographic parameters were evaluated at each level and Area Under the Curve (AUC) was measured. Results: Basal LH model ≥0.14 mIU/mL reached the highest predictability (90.6% and 78.2%, Se and Sp, respectively). Basal LH/FSH ratio ≥0.1 showed a sensitivity of 85.90% and a specificity of 78.14%, while basal FSH cut-off (≥2.36 mIU/mL) had the lowest predictability, with a less favourable sensitivity (71%) and specificity (70.5%). Cut-off point for uterine length as 35 mm, (83.5% and 42.9% of Se and Sp, respectively) was calculated. For ovarian volumes, ROC curves showed very low sensitivity and specificity. Conclusion: A single basal LH measurement under the cut-off limit may be adequate to exclude an HPG axis activation as CPP. [ABSTRACT FROM AUTHOR]
Copyright of Endocrine (1355008X) is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Complementary Index
More Details
ISSN:1355008X
DOI:10.1007/s12020-024-03781-9
Published in:Endocrine (1355008X)
Language:English